Nowadays, cancer has a major impact on society worldwide. In
the India, number is increasing every year with lung, breast,
colorectal/rectum, prostate, and stomach cancers having the highest number of
incidences on a global scale. Prostate cancer has been observed to account for
more than half of the total number of these cancer cases. Prostate cancer
incidence increases steeply with age. Overall, cancer and the care of those who
are diagnosed with cancer is a national expenditure costing high. The risk
factors for prostate cancer include age, family history, ethnicity, diet,
alcohol and smoking, high body weight and physical inactivity, medications,
medical procedures, infections, endogenous hormones, and diabetes mellitus.
Therefore, putting these together will provide a biological indicator of
initiation, progression or spread or response to drug therapy regarding
prostate cancer called prostate cancer biomarker. These biomarkers are
important due to the ease of use as their levels can be elevated or depressed
in response to cancer. In this chapter, we will discuss the biomarker that is
helpful in screening, diagnosis and prognosis of prostate cancer.
Author(s) Details:
Jaswant Kaur,
Department of Biochemistry, Dr. S.S. Tantia Medical College,
Hospital & Research Centre, Sriganganagar, Rajasthan, India.
Mohit
Sharma,
7th
Battalion Punjab Armed Police, Jalandhar Cantonment, Punjab, India.
Seema,
Department of Physiology, Dr. S.S. Tantia Medical College, Hospital
& Research Centre, Sriganganagar, Rajasthan, India.
Rajinder Singh Ahi,
Department of Biochemistry, Guru Gobind Singh Medical College and
Hospital, Faridkot (Punjab), India.
Mridula Mittal,
Department
of Physiology, Adesh Medical College, Bathinda, Punjab, India.
Tejinder
Singh,
Department
of Biochemistry, GMC, Amritsar, Punjab, India.
Please see the link here: https://stm.bookpi.org/ANUMS-V6/article/view/13364
No comments:
Post a Comment